Published on 10/10/202510/10/2025 by Environmental Scientists 54 / 100 Powered by Rank Math SEO SEO Score Assoc. Prof. Dr. Ibrahim Ethem Pinar | Hematology | Best Researcher Award Associate Professor | Bursa Uludag University | Turkey Assoc. Prof. Dr. Ibrahim Ethem Pinar M.D., is an Associate Professor in the Department of Hematology at the Faculty of Medicine, Bursa Uludağ University, Türkiye. He completed his medical education and specialized training in internal medicine and hematology, establishing a strong academic and clinical foundation in the field. His research focuses on acute myeloid leukemia, FLT3-mutated AML, hematopoietic stem-cell transplantation, CMV reactivation, multiple myeloma prognostics, and the integration of artificial intelligence in hematology. Assoc. Prof. Dr. Ibrahim Ethem Pinar has authored impactful research articles published in reputed journals such as the International Journal of Hematology and Oncology, Therapeutic Apheresis and Dialysis, Clinical Lymphoma Myeloma and Leukemia, and Scientific Reports. His scholarly output includes 23 publications with 64 citations across 64 documents and an h-index of 5, reflecting his growing influence in the hematology research community. He has also contributed to book chapters discussing contemporary clinical approaches to hematologic diseases and nanotechnology applications in medicine. Recognized for his contributions to hematologic research, Assoc. Prof. Dr. Ibrahim Ethem Pinar has received multiple awards from the Turkish Society of Hematology and presented his studies at prestigious international conferences, including the American Society of Hematology and the European Society for Blood and Marrow Transplantation. A dedicated educator and clinician, he continues to advance the understanding and management of hematologic malignancies through innovative clinical and translational research. Assoc. Prof. Dr. Ibrahim Ethem Pinar is fluent in Turkish and English and remains deeply engaged in collaborative projects that bridge academic excellence with clinical practice in hematology. Profile: Scopus | Orcid | Google Scholar Featured Publications Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539. Ibrahim Ethem Pinar | Hematology | Best Researcher Award
Assoc. Prof. Dr. Ibrahim Ethem Pinar M.D., is an Associate Professor in the Department of Hematology at the Faculty of Medicine, Bursa Uludağ University, Türkiye. He completed his medical education and specialized training in internal medicine and hematology, establishing a strong academic and clinical foundation in the field. His research focuses on acute myeloid leukemia, FLT3-mutated AML, hematopoietic stem-cell transplantation, CMV reactivation, multiple myeloma prognostics, and the integration of artificial intelligence in hematology. Assoc. Prof. Dr. Ibrahim Ethem Pinar has authored impactful research articles published in reputed journals such as the International Journal of Hematology and Oncology, Therapeutic Apheresis and Dialysis, Clinical Lymphoma Myeloma and Leukemia, and Scientific Reports. His scholarly output includes 23 publications with 64 citations across 64 documents and an h-index of 5, reflecting his growing influence in the hematology research community. He has also contributed to book chapters discussing contemporary clinical approaches to hematologic diseases and nanotechnology applications in medicine. Recognized for his contributions to hematologic research, Assoc. Prof. Dr. Ibrahim Ethem Pinar has received multiple awards from the Turkish Society of Hematology and presented his studies at prestigious international conferences, including the American Society of Hematology and the European Society for Blood and Marrow Transplantation. A dedicated educator and clinician, he continues to advance the understanding and management of hematologic malignancies through innovative clinical and translational research. Assoc. Prof. Dr. Ibrahim Ethem Pinar is fluent in Turkish and English and remains deeply engaged in collaborative projects that bridge academic excellence with clinical practice in hematology. Profile: Scopus | Orcid | Google Scholar
Assoc. Prof. Dr. Ibrahim Ethem Pinar M.D., is an Associate Professor in the Department of Hematology at the Faculty of Medicine, Bursa Uludağ University, Türkiye. He completed his medical education and specialized training in internal medicine and hematology, establishing a strong academic and clinical foundation in the field. His research focuses on acute myeloid leukemia, FLT3-mutated AML, hematopoietic stem-cell transplantation, CMV reactivation, multiple myeloma prognostics, and the integration of artificial intelligence in hematology. Assoc. Prof. Dr. Ibrahim Ethem Pinar has authored impactful research articles published in reputed journals such as the International Journal of Hematology and Oncology, Therapeutic Apheresis and Dialysis, Clinical Lymphoma Myeloma and Leukemia, and Scientific Reports. His scholarly output includes 23 publications with 64 citations across 64 documents and an h-index of 5, reflecting his growing influence in the hematology research community. He has also contributed to book chapters discussing contemporary clinical approaches to hematologic diseases and nanotechnology applications in medicine. Recognized for his contributions to hematologic research, Assoc. Prof. Dr. Ibrahim Ethem Pinar has received multiple awards from the Turkish Society of Hematology and presented his studies at prestigious international conferences, including the American Society of Hematology and the European Society for Blood and Marrow Transplantation. A dedicated educator and clinician, he continues to advance the understanding and management of hematologic malignancies through innovative clinical and translational research. Assoc. Prof. Dr. Ibrahim Ethem Pinar is fluent in Turkish and English and remains deeply engaged in collaborative projects that bridge academic excellence with clinical practice in hematology. Profile: Scopus | Orcid | Google Scholar
Assoc. Prof. Dr. Ibrahim Ethem Pinar M.D., is an Associate Professor in the Department of Hematology at the Faculty of Medicine, Bursa Uludağ University, Türkiye. He completed his medical education and specialized training in internal medicine and hematology, establishing a strong academic and clinical foundation in the field. His research focuses on acute myeloid leukemia, FLT3-mutated AML, hematopoietic stem-cell transplantation, CMV reactivation, multiple myeloma prognostics, and the integration of artificial intelligence in hematology. Assoc. Prof. Dr. Ibrahim Ethem Pinar has authored impactful research articles published in reputed journals such as the International Journal of Hematology and Oncology, Therapeutic Apheresis and Dialysis, Clinical Lymphoma Myeloma and Leukemia, and Scientific Reports. His scholarly output includes 23 publications with 64 citations across 64 documents and an h-index of 5, reflecting his growing influence in the hematology research community. He has also contributed to book chapters discussing contemporary clinical approaches to hematologic diseases and nanotechnology applications in medicine. Recognized for his contributions to hematologic research, Assoc. Prof. Dr. Ibrahim Ethem Pinar has received multiple awards from the Turkish Society of Hematology and presented his studies at prestigious international conferences, including the American Society of Hematology and the European Society for Blood and Marrow Transplantation. A dedicated educator and clinician, he continues to advance the understanding and management of hematologic malignancies through innovative clinical and translational research. Assoc. Prof. Dr. Ibrahim Ethem Pinar is fluent in Turkish and English and remains deeply engaged in collaborative projects that bridge academic excellence with clinical practice in hematology. Profile: Scopus | Orcid | Google Scholar
Assoc. Prof. Dr. Ibrahim Ethem Pinar M.D., is an Associate Professor in the Department of Hematology at the Faculty of Medicine, Bursa Uludağ University, Türkiye. He completed his medical education and specialized training in internal medicine and hematology, establishing a strong academic and clinical foundation in the field. His research focuses on acute myeloid leukemia, FLT3-mutated AML, hematopoietic stem-cell transplantation, CMV reactivation, multiple myeloma prognostics, and the integration of artificial intelligence in hematology. Assoc. Prof. Dr. Ibrahim Ethem Pinar has authored impactful research articles published in reputed journals such as the International Journal of Hematology and Oncology, Therapeutic Apheresis and Dialysis, Clinical Lymphoma Myeloma and Leukemia, and Scientific Reports. His scholarly output includes 23 publications with 64 citations across 64 documents and an h-index of 5, reflecting his growing influence in the hematology research community. He has also contributed to book chapters discussing contemporary clinical approaches to hematologic diseases and nanotechnology applications in medicine. Recognized for his contributions to hematologic research, Assoc. Prof. Dr. Ibrahim Ethem Pinar has received multiple awards from the Turkish Society of Hematology and presented his studies at prestigious international conferences, including the American Society of Hematology and the European Society for Blood and Marrow Transplantation. A dedicated educator and clinician, he continues to advance the understanding and management of hematologic malignancies through innovative clinical and translational research. Assoc. Prof. Dr. Ibrahim Ethem Pinar is fluent in Turkish and English and remains deeply engaged in collaborative projects that bridge academic excellence with clinical practice in hematology. Profile: Scopus | Orcid | Google Scholar
Assoc. Prof. Dr. Ibrahim Ethem Pinar M.D., is an Associate Professor in the Department of Hematology at the Faculty of Medicine, Bursa Uludağ University, Türkiye. He completed his medical education and specialized training in internal medicine and hematology, establishing a strong academic and clinical foundation in the field. His research focuses on acute myeloid leukemia, FLT3-mutated AML, hematopoietic stem-cell transplantation, CMV reactivation, multiple myeloma prognostics, and the integration of artificial intelligence in hematology. Assoc. Prof. Dr. Ibrahim Ethem Pinar has authored impactful research articles published in reputed journals such as the International Journal of Hematology and Oncology, Therapeutic Apheresis and Dialysis, Clinical Lymphoma Myeloma and Leukemia, and Scientific Reports. His scholarly output includes 23 publications with 64 citations across 64 documents and an h-index of 5, reflecting his growing influence in the hematology research community. He has also contributed to book chapters discussing contemporary clinical approaches to hematologic diseases and nanotechnology applications in medicine. Recognized for his contributions to hematologic research, Assoc. Prof. Dr. Ibrahim Ethem Pinar has received multiple awards from the Turkish Society of Hematology and presented his studies at prestigious international conferences, including the American Society of Hematology and the European Society for Blood and Marrow Transplantation. A dedicated educator and clinician, he continues to advance the understanding and management of hematologic malignancies through innovative clinical and translational research. Assoc. Prof. Dr. Ibrahim Ethem Pinar is fluent in Turkish and English and remains deeply engaged in collaborative projects that bridge academic excellence with clinical practice in hematology. Profile: Scopus | Orcid | Google Scholar
Assoc. Prof. Dr. Ibrahim Ethem Pinar M.D., is an Associate Professor in the Department of Hematology at the Faculty of Medicine, Bursa Uludağ University, Türkiye. He completed his medical education and specialized training in internal medicine and hematology, establishing a strong academic and clinical foundation in the field. His research focuses on acute myeloid leukemia, FLT3-mutated AML, hematopoietic stem-cell transplantation, CMV reactivation, multiple myeloma prognostics, and the integration of artificial intelligence in hematology. Assoc. Prof. Dr. Ibrahim Ethem Pinar has authored impactful research articles published in reputed journals such as the International Journal of Hematology and Oncology, Therapeutic Apheresis and Dialysis, Clinical Lymphoma Myeloma and Leukemia, and Scientific Reports. His scholarly output includes 23 publications with 64 citations across 64 documents and an h-index of 5, reflecting his growing influence in the hematology research community. He has also contributed to book chapters discussing contemporary clinical approaches to hematologic diseases and nanotechnology applications in medicine. Recognized for his contributions to hematologic research, Assoc. Prof. Dr. Ibrahim Ethem Pinar has received multiple awards from the Turkish Society of Hematology and presented his studies at prestigious international conferences, including the American Society of Hematology and the European Society for Blood and Marrow Transplantation. A dedicated educator and clinician, he continues to advance the understanding and management of hematologic malignancies through innovative clinical and translational research. Assoc. Prof. Dr. Ibrahim Ethem Pinar is fluent in Turkish and English and remains deeply engaged in collaborative projects that bridge academic excellence with clinical practice in hematology. Profile: Scopus | Orcid | Google Scholar
Assoc. Prof. Dr. Ibrahim Ethem Pinar M.D., is an Associate Professor in the Department of Hematology at the Faculty of Medicine, Bursa Uludağ University, Türkiye. He completed his medical education and specialized training in internal medicine and hematology, establishing a strong academic and clinical foundation in the field. His research focuses on acute myeloid leukemia, FLT3-mutated AML, hematopoietic stem-cell transplantation, CMV reactivation, multiple myeloma prognostics, and the integration of artificial intelligence in hematology. Assoc. Prof. Dr. Ibrahim Ethem Pinar has authored impactful research articles published in reputed journals such as the International Journal of Hematology and Oncology, Therapeutic Apheresis and Dialysis, Clinical Lymphoma Myeloma and Leukemia, and Scientific Reports. His scholarly output includes 23 publications with 64 citations across 64 documents and an h-index of 5, reflecting his growing influence in the hematology research community. He has also contributed to book chapters discussing contemporary clinical approaches to hematologic diseases and nanotechnology applications in medicine. Recognized for his contributions to hematologic research, Assoc. Prof. Dr. Ibrahim Ethem Pinar has received multiple awards from the Turkish Society of Hematology and presented his studies at prestigious international conferences, including the American Society of Hematology and the European Society for Blood and Marrow Transplantation. A dedicated educator and clinician, he continues to advance the understanding and management of hematologic malignancies through innovative clinical and translational research. Assoc. Prof. Dr. Ibrahim Ethem Pinar is fluent in Turkish and English and remains deeply engaged in collaborative projects that bridge academic excellence with clinical practice in hematology. Profile: Scopus | Orcid | Google Scholar
Assoc. Prof. Dr. Ibrahim Ethem Pinar M.D., is an Associate Professor in the Department of Hematology at the Faculty of Medicine, Bursa Uludağ University, Türkiye. He completed his medical education and specialized training in internal medicine and hematology, establishing a strong academic and clinical foundation in the field. His research focuses on acute myeloid leukemia, FLT3-mutated AML, hematopoietic stem-cell transplantation, CMV reactivation, multiple myeloma prognostics, and the integration of artificial intelligence in hematology. Assoc. Prof. Dr. Ibrahim Ethem Pinar has authored impactful research articles published in reputed journals such as the International Journal of Hematology and Oncology, Therapeutic Apheresis and Dialysis, Clinical Lymphoma Myeloma and Leukemia, and Scientific Reports. His scholarly output includes 23 publications with 64 citations across 64 documents and an h-index of 5, reflecting his growing influence in the hematology research community. He has also contributed to book chapters discussing contemporary clinical approaches to hematologic diseases and nanotechnology applications in medicine. Recognized for his contributions to hematologic research, Assoc. Prof. Dr. Ibrahim Ethem Pinar has received multiple awards from the Turkish Society of Hematology and presented his studies at prestigious international conferences, including the American Society of Hematology and the European Society for Blood and Marrow Transplantation. A dedicated educator and clinician, he continues to advance the understanding and management of hematologic malignancies through innovative clinical and translational research. Assoc. Prof. Dr. Ibrahim Ethem Pinar is fluent in Turkish and English and remains deeply engaged in collaborative projects that bridge academic excellence with clinical practice in hematology. Profile: Scopus | Orcid | Google Scholar
Assoc. Prof. Dr. Ibrahim Ethem Pinar M.D., is an Associate Professor in the Department of Hematology at the Faculty of Medicine, Bursa Uludağ University, Türkiye. He completed his medical education and specialized training in internal medicine and hematology, establishing a strong academic and clinical foundation in the field. His research focuses on acute myeloid leukemia, FLT3-mutated AML, hematopoietic stem-cell transplantation, CMV reactivation, multiple myeloma prognostics, and the integration of artificial intelligence in hematology. Assoc. Prof. Dr. Ibrahim Ethem Pinar has authored impactful research articles published in reputed journals such as the International Journal of Hematology and Oncology, Therapeutic Apheresis and Dialysis, Clinical Lymphoma Myeloma and Leukemia, and Scientific Reports. His scholarly output includes 23 publications with 64 citations across 64 documents and an h-index of 5, reflecting his growing influence in the hematology research community. He has also contributed to book chapters discussing contemporary clinical approaches to hematologic diseases and nanotechnology applications in medicine. Recognized for his contributions to hematologic research, Assoc. Prof. Dr. Ibrahim Ethem Pinar has received multiple awards from the Turkish Society of Hematology and presented his studies at prestigious international conferences, including the American Society of Hematology and the European Society for Blood and Marrow Transplantation. A dedicated educator and clinician, he continues to advance the understanding and management of hematologic malignancies through innovative clinical and translational research. Assoc. Prof. Dr. Ibrahim Ethem Pinar is fluent in Turkish and English and remains deeply engaged in collaborative projects that bridge academic excellence with clinical practice in hematology. Profile: Scopus | Orcid | Google Scholar
Assoc. Prof. Dr. Ibrahim Ethem Pinar M.D., is an Associate Professor in the Department of Hematology at the Faculty of Medicine, Bursa Uludağ University, Türkiye. He completed his medical education and specialized training in internal medicine and hematology, establishing a strong academic and clinical foundation in the field. His research focuses on acute myeloid leukemia, FLT3-mutated AML, hematopoietic stem-cell transplantation, CMV reactivation, multiple myeloma prognostics, and the integration of artificial intelligence in hematology. Assoc. Prof. Dr. Ibrahim Ethem Pinar has authored impactful research articles published in reputed journals such as the International Journal of Hematology and Oncology, Therapeutic Apheresis and Dialysis, Clinical Lymphoma Myeloma and Leukemia, and Scientific Reports. His scholarly output includes 23 publications with 64 citations across 64 documents and an h-index of 5, reflecting his growing influence in the hematology research community. He has also contributed to book chapters discussing contemporary clinical approaches to hematologic diseases and nanotechnology applications in medicine. Recognized for his contributions to hematologic research, Assoc. Prof. Dr. Ibrahim Ethem Pinar has received multiple awards from the Turkish Society of Hematology and presented his studies at prestigious international conferences, including the American Society of Hematology and the European Society for Blood and Marrow Transplantation. A dedicated educator and clinician, he continues to advance the understanding and management of hematologic malignancies through innovative clinical and translational research. Assoc. Prof. Dr. Ibrahim Ethem Pinar is fluent in Turkish and English and remains deeply engaged in collaborative projects that bridge academic excellence with clinical practice in hematology. Profile: Scopus | Orcid | Google Scholar
Featured Publications Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.
Featured Publications Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.
Featured Publications Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.
Featured Publications Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.
Featured Publications Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.
Featured Publications Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.
Featured Publications Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.
Featured Publications Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.
Featured Publications Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.
Featured Publications Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.
Featured Publications Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.
Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.
Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7). Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304. Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051. Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057. Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.